ERCC2 and hepatocellular carcinoma: Over the last 2 decades, a number of epidemiological studies have been conducted to investigate the associations between XPD Lys751Gln and Asp312Asn polymorphisms and HCC risk, but the results remain inconsistent and underpowered.